The effect of comorbidities on COPD assessment: a pilot study

Area of Science:

• Pulmonary Medicine
• Respiratory Health
• Clinical Research

Background:

• Chronic Obstructive Pulmonary Disease (COPD) patients often have multiple comorbidities.
• The Global Initiative for Chronic Obstructive Lung Disease (GOLD) score is used to assess COPD severity.
• Lung function tests and imaging are crucial for evaluating COPD pathology.

Purpose of the Study:

• To assess the association between GOLD score and lung function measurements in COPD patients.
• To determine if comorbidities influence the GOLD score's evaluation of COPD severity.
• To investigate if the GOLD score better represents overall morbidity than COPD severity.

Main Methods:

• Prospective study of 106 stable COPD patients (excluding lung cancer patients).
• Recorded demographics, SpO2, mMRC, exacerbations, and comorbidities.
• Measured lung function (body plethysmography, DLCO), HR-CT (emphysema, airways disease), and stratified by GOLD score.

Main Results:

• GOLD score associated with emphysema and lung function, but associations weakened with >1 comorbidity.
• Significant differences found in GOLD score, FEV1%, and IC/TLC between subgroups.
• Comorbidities were linked to GOLD score and composite measures via cluster analysis.

Conclusions:

• Comorbidities affect the relationship between GOLD score and lung function.
• The GOLD score may be a better indicator of overall patient morbidity than COPD severity alone.